Abstract

KEY POINTS

1. cfDNA yield and variant allele frequencies (VAFs) correlate with GBM tumor burden.
2. cfDNA properties can be used to differentiate between cell types in a mixed population.
3. TMZ treatment increases cfDNA yield and VAFs, reflecting treatment response.

IMPORTANCE OF THE STUDY